Published in ACS Chem Biol on October 16, 2009
A widespread family of bacterial cell wall assembly proteins. EMBO J (2011) 2.33
Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem (2010) 2.15
Wall teichoic acids of gram-positive bacteria. Annu Rev Microbiol (2013) 1.77
Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol (2010) 1.64
Antibacterial drug discovery in the resistance era. Nature (2016) 1.40
Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibiotics. BMC Microbiol (2011) 1.35
Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to β-lactams. ACS Chem Biol (2012) 1.29
Selective small-molecule inhibition of an RNA structural element. Nature (2015) 1.11
Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agents. Chem Biol (2013) 1.07
ε/ζ systems: their role in resistance, virulence, and their potential for antibiotic development. J Mol Med (Berl) (2011) 1.04
Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009. J Comb Chem (2010) 1.03
An antibiotic that inhibits a late step in wall teichoic acid biosynthesis induces the cell wall stress stimulon in Staphylococcus aureus. Antimicrob Agents Chemother (2012) 0.98
Teichoic acid biosynthesis as an antibiotic target. Curr Opin Microbiol (2013) 0.97
Detection of lipid-linked peptidoglycan precursors by exploiting an unexpected transpeptidase reaction. J Am Chem Soc (2014) 0.97
Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus. Bioorg Med Chem Lett (2010) 0.97
Use of a bacteriophage lysin to identify a novel target for antimicrobial development. PLoS One (2013) 0.93
ABC transporters required for export of wall teichoic acids do not discriminate between different main chain polymers. ACS Chem Biol (2011) 0.93
In vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates. Antimicrob Agents Chemother (2010) 0.92
A Streptococcus pneumoniae infection model in larvae of the wax moth Galleria mellonella. Eur J Clin Microbiol Infect Dis (2012) 0.91
Lipid-linked cell wall precursors regulate membrane association of bacterial actin MreB. Nat Chem Biol (2014) 0.90
Role of wall teichoic acids in Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci (2011) 0.89
Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase. Proc Natl Acad Sci U S A (2015) 0.89
Validation of inhibitors of an ABC transporter required to transport lipopolysaccharide to the cell surface in Escherichia coli. Bioorg Med Chem (2013) 0.88
Development of an activity assay for discovery of inhibitors of lipopolysaccharide transport. J Am Chem Soc (2010) 0.88
Staphylococcus aureus and Bacillus subtilis W23 make polyribitol wall teichoic acids using different enzymatic pathways. Chem Biol (2010) 0.86
Two-component system cross-regulation integrates Bacillus anthracis response to heme and cell envelope stress. PLoS Pathog (2014) 0.83
Discovery of novel cell wall-active compounds using P ywaC, a sensitive reporter of cell wall stress, in the model gram-positive bacterium Bacillus subtilis. Antimicrob Agents Chemother (2014) 0.82
Wall teichoic acid protects Staphylococcus aureus from inhibition by Congo red and other dyes. J Antimicrob Chemother (2012) 0.82
The Listeria monocytogenes PASTA Kinase PrkA and Its Substrate YvcK Are Required for Cell Wall Homeostasis, Metabolism, and Virulence. PLoS Pathog (2016) 0.81
High-throughput assessment of bacterial growth inhibition by optical density measurements. Curr Protoc Chem Biol (2011) 0.81
Chemical Genetic Analysis and Functional Characterization of Staphylococcal Wall Teichoic Acid 2-Epimerases Reveals Unconventional Antibiotic Drug Targets. PLoS Pathog (2016) 0.78
Envelope Structures of Gram-Positive Bacteria. Curr Top Microbiol Immunol (2016) 0.76
The Staphylococcus aureus Methicillin Resistance Factor FmtA Is a d-Amino Esterase That Acts on Teichoic Acids. MBio (2016) 0.76
Accelerating the discovery of antibacterial compounds using pathway-directed whole cell screening. Bioorg Med Chem (2016) 0.75
Multidrug Intrinsic Resistance Factors in Staphylococcus aureus Identified by Profiling Fitness within High-Diversity Transposon Libraries. MBio (2016) 0.75
Efficacy of ampicillin against methicillin-resistant Staphylococcus aureus restored through synergy with branched poly(ethylenimine). J Antibiot (Tokyo) (2016) 0.75
Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol Lett (1992) 6.18
Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid (2005) 6.11
Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med (2004) 5.21
A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol Mol Biol Rev (2003) 5.18
Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol (2007) 4.83
Bacteriophage receptors. Annu Rev Microbiol (1973) 4.45
The research agenda of the National Institute of Allergy and Infectious Diseases for antimicrobial resistance. J Infect Dis (2008) 3.84
The biology and future prospects of antivirulence therapies. Nat Rev Microbiol (2008) 3.83
Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol (2008) 3.57
Targeting QseC signaling and virulence for antibiotic development. Science (2008) 3.26
Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science (2005) 3.26
A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science (2008) 2.96
Antibiotic interactions that select against resistance. Nature (2007) 2.70
Identification, evolution, and essentiality of the mevalonate pathway for isopentenyl diphosphate biosynthesis in gram-positive cocci. J Bacteriol (2000) 2.50
Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway. J Bacteriol (2006) 2.49
Teichoic and teichuronic acids: biosynthesis, assembly, and location. Microbiol Rev (1981) 2.27
Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis (2008) 2.16
Identification and functional analysis of novel (p)ppGpp synthetase genes in Bacillus subtilis. Mol Microbiol (2007) 1.91
Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect Dis (2005) 1.90
Biosynthesis of cell wall lipopolysaccharide in mutants of Salmonella. V. A mutant of Salmonella typhimurium defective in the synthesis of cytidine diphosphoabequose. J Bacteriol (1969) 1.78
Xanthomonas campestris pv. campestris gum mutants: effects on xanthan biosynthesis and plant virulence. J Bacteriol (1998) 1.70
ppGpp: stringent response and survival. J Microbiol (2006) 1.66
A revised pathway proposed for Staphylococcus aureus wall teichoic acid biosynthesis based on in vitro reconstitution of the intracellular steps. Chem Biol (2008) 1.52
Complex formation between bacitracin peptides and isoprenyl pyrophosphates. The specificity of lipid-peptide interactions. J Biol Chem (1973) 1.51
Accumulation of the enterobacterial common antigen lipid II biosynthetic intermediate stimulates degP transcription in Escherichia coli. J Bacteriol (1998) 1.43
Biosynthesis of the unit that links teichoic acid to the bacterial wall: inhibition by tunicamycin. FEBS Lett (1976) 1.37
Antivirulence as a new antibacterial approach for chemotherapy. Curr Opin Chem Biol (2008) 1.34
Effect of wzx (rfbX) mutations on A-band and B-band lipopolysaccharide biosynthesis in Pseudomonas aeruginosa O5. J Bacteriol (1999) 1.31
Late-stage polyribitol phosphate wall teichoic acid biosynthesis in Staphylococcus aureus. J Bacteriol (2008) 1.22
Inhibition of the D-alanine:D-alanyl carrier protein ligase from Bacillus subtilis increases the bacterium's susceptibility to antibiotics that target the cell wall. FEBS J (2005) 1.21
The N-acetylmannosamine transferase catalyzes the first committed step of teichoic acid assembly in Bacillus subtilis and Staphylococcus aureus. J Bacteriol (2009) 1.16
Expression of heterologous genes for wall teichoic acid in Bacillus subtilis 168. Mol Gen Genet (1987) 1.14
Biosynthesis of the tunicamycins: a review. J Antibiot (Tokyo) (2007) 1.13
Current understanding on biosynthesis of microbial polysaccharides. Curr Top Med Chem (2008) 1.09
Chemical composition and structure of cell wall teichoic acids of staphylococci. Arch Microbiol (1983) 1.08
Probing teichoic acid genetics with bioactive molecules reveals new interactions among diverse processes in bacterial cell wall biogenesis. Chem Biol (2009) 1.04
Pseudo-allelic relationship between non-homologous genes concerned with biosynthesis of polyglycerol phosphate and polyribitol phosphate teichoic acids in Bacillus subtilis strains 168 and W23. Mol Microbiol (1989) 0.99
The mevalonate pathway of Staphylococcus aureus. J Bacteriol (2008) 0.98
Duplication of teichoic acid biosynthetic genes in Staphylococcus aureus leads to functionally redundant poly(ribitol phosphate) polymerases. J Bacteriol (2008) 0.88
Modular epistasis in yeast metabolism. Nat Genet (2004) 8.64
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56
Avian flu: isolation of drug-resistant H5N1 virus. Nature (2005) 6.66
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature (2004) 6.11
The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res (2013) 5.66
The bacterial cell envelope. Cold Spring Harb Perspect Biol (2010) 5.14
Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet (2011) 4.81
The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One (2008) 4.32
Tackling antibiotic resistance. Nat Rev Microbiol (2011) 3.95
Functional classification of drugs by properties of their pairwise interactions. Nat Genet (2006) 3.75
Screening and counselling in the primary care setting for women who have experienced intimate partner violence (WEAVE): a cluster randomised controlled trial. Lancet (2013) 3.74
An equivalence principle for the incorporation of favorable mutations in asexual populations. Science (2006) 3.73
A two-step method for marking polypectomy sites in the colon and rectum. Gastrointest Endosc (2003) 3.63
Translesion synthesis: Y-family polymerases and the polymerase switch. DNA Repair (Amst) (2007) 3.27
Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis. Nature (2002) 3.03
IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol (2005) 3.02
Bacterial persistence: a model of survival in changing environments. Genetics (2005) 2.97
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet (2011) 2.86
Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development (2009) 2.83
Kinetics of morphogen gradient formation. Science (2007) 2.73
Antibiotic interactions that select against resistance. Nature (2007) 2.70
Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science (2013) 2.61
Genomic-scale prioritization of drug targets: the TDR Targets database. Nat Rev Drug Discov (2008) 2.58
Lipoprotein cofactors located in the outer membrane activate bacterial cell wall polymerases. Cell (2010) 2.53
Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibiotics. Proc Natl Acad Sci U S A (2006) 2.53
Accelerated evolution of resistance in multidrug environments. Proc Natl Acad Sci U S A (2008) 2.45
Drug interactions and the evolution of antibiotic resistance. Nat Rev Microbiol (2009) 2.40
Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2004) 2.35
Genetic diversity among Enterococcus faecalis. PLoS One (2007) 2.32
Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction. Nature (2002) 2.29
Native microbial colonization of Drosophila melanogaster and its use as a model of Enterococcus faecalis pathogenesis. Infect Immun (2007) 2.29
Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell (2009) 2.27
Discovery of O-GlcNAc transferase inhibitors. J Am Chem Soc (2005) 2.27
Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes. J Biol Chem (2003) 2.26
Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol (2004) 2.25
Structure of human O-GlcNAc transferase and its complex with a peptide substrate. Nature (2011) 2.24
Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev (2011) 2.22
Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains. MBio (2013) 2.20
Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev (2002) 2.18
Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem (2010) 2.15
Multidrug-resistant enterococci lack CRISPR-cas. MBio (2010) 2.11
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem (2011) 2.11
Long-tube insertion with the ropeway method facilitated by a guidewire placed by transnasal ultrathin endoscopy for bowel obstruction: a prospective, randomized, controlled trial. Gastrointest Endosc (2009) 2.10
Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol (2005) 2.09
Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep (2007) 2.04
Crystal structure of the MurG:UDP-GlcNAc complex reveals common structural principles of a superfamily of glycosyltransferases. Proc Natl Acad Sci U S A (2003) 2.02
Functions of MUC16 in corneal epithelial cells. Invest Ophthalmol Vis Sci (2007) 2.01
Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma--an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy. Expert Opin Ther Targets (2012) 2.00
Variable lymphocyte receptors in hagfish. Proc Natl Acad Sci U S A (2005) 1.99
Drug interactions modulate the potential for evolution of resistance. Proc Natl Acad Sci U S A (2008) 1.98
Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate. Proc Natl Acad Sci U S A (2003) 1.96
Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells (2009) 1.96
Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. Hypertension (2010) 1.91
Regulation of cell size in response to nutrient availability by fatty acid biosynthesis in Escherichia coli. Proc Natl Acad Sci U S A (2012) 1.91
In vitro reconstitution of two essential steps in wall teichoic acid biosynthesis. ACS Chem Biol (2006) 1.89
Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study. AIDS (2013) 1.88
Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5. Sci Signal (2011) 1.88
Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci (2009) 1.85
Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis. Infect Immun (2004) 1.84
Enterococcus faecalis senses target cells and in response expresses cytolysin. Science (2004) 1.83
Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1. J Biol Chem (2002) 1.81
Exposing the fitness contribution of duplicated genes. Nat Genet (2008) 1.80
Chemical decay of an antibiotic inverts selection for resistance. Nat Chem Biol (2010) 1.80
Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics. Sci Transl Med (2012) 1.80
Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett (2004) 1.77
Wall teichoic acids of gram-positive bacteria. Annu Rev Microbiol (2013) 1.77
The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol (2003) 1.77
Genetic basis for daptomycin resistance in enterococci. Antimicrob Agents Chemother (2011) 1.74
Regulation of proliferating cell nuclear antigen ubiquitination in mammalian cells. Proc Natl Acad Sci U S A (2008) 1.73
Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation (2010) 1.72
Analysis of genetic systems using experimental evolution and whole-genome sequencing. Genome Biol (2007) 1.72
Influenza A (H5N1) viruses from pigs, Indonesia. Emerg Infect Dis (2010) 1.70
Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. Genome Res (2009) 1.68
Differential expression of virulence-related genes in Enterococcus faecalis in response to biological cues in serum and urine. Infect Immun (2002) 1.68
Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res (2007) 1.68
Crystal structure of a peptidoglycan glycosyltransferase suggests a model for processive glycan chain synthesis. Proc Natl Acad Sci U S A (2007) 1.68
The capsular polysaccharide of Enterococcus faecalis and its relationship to other polysaccharides in the cell wall. Proc Natl Acad Sci U S A (2002) 1.68
High-quality draft genome sequences of 28 Enterococcus sp. isolates. J Bacteriol (2010) 1.67
Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab (2002) 1.66
PRISM (Program of Resources, Information and Support for Mothers) Protocol for a community-randomised trial [ISRCTN03464021]. BMC Public Health (2003) 1.66
Resolution of gene regulatory conflicts caused by combinations of antibiotics. Mol Cell (2011) 1.65
Antibiotic-resistant enterococci: the mechanisms and dynamics of drug introduction and resistance. Microbes Infect (2002) 1.65
Genome sequencing reveals diversification of virulence factor content and possible host adaptation in distinct subpopulations of Salmonella enterica. BMC Genomics (2011) 1.64
Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol (2010) 1.64
Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011. Breast Cancer (2015) 1.64
Mechanism of chromosomal transfer of Enterococcus faecalis pathogenicity island, capsule, antimicrobial resistance, and other traits. Proc Natl Acad Sci U S A (2010) 1.58
The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J Neurobiol (2003) 1.58
Remarkable structural similarities between diverse glycosyltransferases. Chem Biol (2002) 1.56
Structure and evolution of Streptomyces interaction networks in soil and in silico. PLoS Biol (2011) 1.56
Quorum sensing and DNA release in bacterial biofilms. Curr Opin Microbiol (2006) 1.56
Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci (2012) 1.54
Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr Protein Pept Sci (2005) 1.54
Nongenetic individuality in the host-phage interaction. PLoS Biol (2008) 1.54
Dissecting human adrenal androgen production. Trends Endocrinol Metab (2002) 1.52